Santa Rosa, CA4 Active Studies

Breast Cancer Clinical Trials in Santa Rosa, CA

Find 4 actively recruiting breast cancer clinical trials in Santa Rosa, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
2
Sponsors
2,488
Enrolling

Recruiting Breast Cancer Studies in Santa Rosa

RecruitingSanta Rosa, CANCT04862663

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

A Phase Ib/III Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Fact...

895 participants
AstraZeneca
View Study Details
RecruitingSanta Rosa, CANCT06103864

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without durvalumab compared with investigator's choice chemot...

625 participants
AstraZeneca
View Study Details
RecruitingSanta Rosa, CANCT05696626

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- ...

500 participants
Sermonix Pharmaceuticals Inc.
View Study Details
RecruitingSanta Rosa, CANCT04482309

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors

This is an open-label, multi-center, multi-cohort, Phase 2 study to evaluate the efficacy and safety of trastuzumab deruxtecan (T-DXd) for the treatment of selected HER2-expressing tumors. This study...

468 participants
AstraZeneca
View Study Details

About Breast Cancer Clinical Trials in Santa Rosa

Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.

There are currently 4 breast cancer clinical trials recruiting participants in Santa Rosa, CA. These studies are seeking a combined 2,488 participants. Research is being sponsored by AstraZeneca, Sermonix Pharmaceuticals Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Breast Cancer Clinical Trials in Santa Rosa — FAQ

Are there breast cancer clinical trials in Santa Rosa?

Yes, there are 4 breast cancer clinical trials currently recruiting in Santa Rosa, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Rosa?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Rosa research site will contact you about next steps.

Are clinical trials in Santa Rosa free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Rosa studies also compensate for your time and travel.

What breast cancer treatments are being tested?

The 4 active trials in Santa Rosa are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.

Data updated March 2, 2026 from ClinicalTrials.gov